Dr. Beth Karlan is a leader in the field of research on early detection of ovarian cancer. She has received research grants from the Department of Defense, National Institutes of Health and the American Cancer Institute. Her research interests include the genetic definition and phenotypic determinants of human ovarian carcinomas, molecular biomarker discovery and inherited cancer susceptibility. This year, she is our winner of the Rosalind Franklin Excellence in Ovarian Cancer Research Award due to her commitment to innovative ovarian cancer research.
Related Topics
OCRA’s International Gynecologic Cancer Conference® Session Recordings Now Available to Watch Free Online
Watch expert sessions on ovarian, endometrial, cervical, and rare gynecologic cancers, and more This September, more than 2,180 people from 65 countries came together for OCRA’s 2026 International Gynecologic Cancer Conference® to learn the latest updates, gain resources for navigating gynecologic cancer, and find support, community, and hope. If you couldn’t join us live, or … Continued
Bipartisan Legislation Introduced to Improve Prevention, Testing and Care for Gynecologic Cancers
Ovarian Cancer IMPACT Act would expand access to genetic testing and counseling, risk-reducing care, education and specialized care for patients and families WASHINGTON, D.C. — September 29, 2026 — Ovarian Cancer Research Alliance (OCRA) today joined patients, survivors, and advocates in celebrating the introduction of the Ovarian Cancer Improving and Modernizing Prevention, Access, Care, and Testing … Continued
The Overview: August 2026
September is Ovarian and Gynecologic Cancer Awareness Month—a time for our community to unite, raise awareness, and push forward in the search for better treatments and cures. This year, that push forward took a major step. In May, we launched the Research Exchange, a new kind of online community that represents a fundamental shift in how … Continued